Life Sciences + Health
Bridging Global Communications in 200+ languages
Women’s History Month: Recognizing Women Research Pioneers in the Health Sciences
Today in the world of medicine we are accustomed to hearing about breakthrough contributions from scientists and researchers of all genders, but for much of the past century this wasn’t the case. While many women have played an important role in the advancement...
What Does Stress Do To Our Body?
This article is part 1 of a mini-series focusing on how the body reacts to stressors. This installment looks at the physiological reaction to stress and how this can impact a person’s overall health. Have you ever thought about what stress could do to your body? You...
Women’s History Month: The Importance of Inclusive Clinical Trials on Care and Society
With March being Women’s History Month, we remember that women have historically been marginalized and how important it is to work towards women’s empowerment. Activists like Margaret Sanger, who popularized the term birth control, and Katherine McCormick, who Sanger...
Who We Are
CSOFT Health Sciences has over 15 years of experience providing end-to-end translation and localization solutions for all stages of the product life cycle, from pre-clinical to post-launch. We also specialize in China market access consulting services, Asian regulatory and eCTD submissions. Our operation is compliant with ISO 17100 and certified by BSI in ISO 9001:2015 and ISO 13485:2016, providing customized solutions to meet the rigorous regulatory requirements in global submission.
How We Serve You
We are dedicated to industry-standard knowledge and quality.
Our translation solutions are intended for document types relating to every stage of product development life cycle. CSOFT works extensively with medical professionals who are dedicated to prevalent therapeutic areas such as:
- Cardiology
- Dental
- Dermatology
- Gastroenterology
- Infections
- Neurology
- Oncology
- Orthopedics
- Genetic Disease
- Hematology
- Hepatology
- Immunology
- Pediatrics
- Psychology
- Rare Diseases
- Women’s Health
Asia Regulatory Services
Regulatory Digest
CSOFT life science blog aims to provide a better understanding of complex diseases, and regulatory polices from conducting experiments to introducing new type of drugs into the market.
China Creating a Framework on Real-World Evidence
Purpose of Real-World Evidence/Real-World Data To test new treatments, pharmaceutical companies adopt a method called "Randomized Controlled Trial" (RCT). There are two design groups within a trial. Participants from the "Randomized" group are chosen...
China Finalized the Trade Agreement for Patent Drug with the U.S.
Trade Agreement On January 16, 2020 the U.S. and China finalized the trade agreement that specifies the patent protection rules for drugs. Under the patent protection, biopharmaceutical companies can fill out an application and the term of each new patent is 20 years....
Beigene, the First Pharma Company to Receive FDA’s Approval for Cancer Drug
On November 14, 2019, the U.S. Food and Drug Administration gave approval to BeiGene Ltd's lymphoma treatment. BeiGene is a Chinese biopharmaceutical company that focused on cancer treatments. The treatment "Brukinsa" has been tested on 118 patients with mantle cell...